Minnesota 2025-2026 Regular Session

Minnesota Senate Bill SF4138

Introduced
3/4/26  

Caption

Definition for covered insulin for the insulin safety net program and manufacturer registration fee provision

Impact

The bill impacts state laws by amending existing healthcare regulations, specifically those related to prescription drug coverage and patient assistance. It seeks to improve accessibility to insulin for diabetic patients who may not have adequate insurance coverage or funds to purchase necessary supplies. Individuals eligible for the program must attest to their Minnesota residency and not be enrolled in other assistance programs that limit co-payments, among other stipulations. Furthermore, the bill integrally ties the reimbursement and assistance to insurer accountability, aiming to reduce the financial burden on vulnerable populations needing urgent insulin access.

Summary

S.F. No. 4138 is a legislative bill that establishes a safety net program for individuals in urgent need of insulin in Minnesota. The bill defines 'covered insulin' and outlines the responsibilities of manufacturers in making this critical medication accessible. The legislation mandates that insulin manufacturers create protocol to aid residents who demonstrate urgent need—defined as having less than a week’s supply of insulin available. These manufacturers are required to set up patient assistance programs, with stated eligibility criteria to ensure fair access, thus helping many patients who may face financial barriers in obtaining essential medication in a timely manner.

Contention

Although the bill outlines a framework for insulin accessibility, it might face scrutiny regarding its provisions, including the stipulations surrounding eligibility and potential burdens on manufacturers regarding compliance. Some stakeholders may argue about the risk of increased costs to manufacturers or insurance providers, which could ultimately impact pricing structures. Additionally, there may be debate regarding the equitable access to the program across different demographic groups, as legislators and advocacy groups weigh the necessity of these safety net provisions against operational complexity and compliance costs.

Companion Bills

MN HF3756

Similar To Definition for covered insulin provided for the insulin safety net program and manufacturer registration fee.

Previously Filed As

MN HF3756

Definition for covered insulin provided for the insulin safety net program and manufacturer registration fee.

MN HF2275

Insulin manufacturer registration fee provisions modified.

MN HB897

Urgent Insulin Safety Net Program Act; enact

MN SB175

Enacts provisions relating to insurance coverage for prescription insulin drugs

MN SB1156

Enacts provisions relating to insurance coverage for prescription insulin drugs

MN HB3117

Enacts provisions relating to insurance coverage for prescription insulin drugs

MN HB305

In casualty insurance, providing for coverage for insulin.

MN HF4466

Health and human services finance and policy bill.

MN S01917

Establishes an emergency insulin program and corresponding emergency insulin program trust fund to facilitate emergency access to analog insulins.

MN HB898

Continuing Insulin Safety Net Act; enact

Similar Bills

MN HF3284

REAL ID implementation law repealed.

MN SF3492

REAL ID implementation law repealer

MN HF4324

Windom authorized to impose local sales and use tax.

MN SF3827

Eligibility modification of certain applicants for licenses to serve as private detectives or protective agents

MN SF3664

Omnibus Jobs and Economic Development policy and supplemental appropriations

MN SF4417

City on Windom local sales and use tax imposition authorization provision

MN HF4151

Eligibility of certain applicants for licenses to serve as private detectives or protective agents modified.

MN SF5006

City of St. Peter local sales tax provision modification